Skip to Main Content

Paper Details

CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2.
bioRxiv
74
2021
ACE2, CD209, CD209L, COVID-19, DC-SIGN, L-SIGN, N, NTB, S-RBD, S1, SARS, SARS-, SARS-CoV, SARS-CoV-2, cell types, disease, human, human cells, human endothelial cells, recombinant SARS-CoV-2 spike receptor binding domain
Author NameAffiliation
Ellen L SuderBoston University School of Medicine
Ellen L SuderBoston University
Catherine E CostelloCenter for Biomedical Mass Spectrometry, Boston University School of Medicine
Catherine E CostelloCenter for Biomedical Mass Spectrometry, Boston University School of Medicine
  • 1 - 4

Datasets

Release 1.2